US › Healthcare

Lunai Bioworks Inc. (LNAI)

US · Healthcare · Biotechnology

$0.68-17.68%

Last close · 2026-10-16

Latest quarter · ended 2026-03-31

Revenue

$20,942

Net profit

$-2.6M

Profit YoY

-1459.3%

EPS

$-0.10

Net margin

-12,278.6%

Key statistics

Market cap

$3.7M

Forward P/E

0.0

P/B

0.48

Book value

$-1.96

EPS (TTM)

$-1.06

52-week high

$13.28

52-week low

$0.66

50-day MA

$2.02

200-day MA

$3.30

Beta

0.35

Shareholding

Insiders

40.72%

Institutions

4.36%

Largest institutional holders

Fund	Stake
Ground Swell Capital, LLC	1.17%
State Street Corp	0.83%
Geode Capital Management, LLC	0.53%
Jane Street Group LLC	0.52%
Vanguard Capital Management, LLC	0.35%
BlackRock Inc	0.35%
Virtu Financial LLC	0.28%
Vanguard Fiduciary Trust Co	0.19%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Lunai Bioworks Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.